Skip to content
MyFreud

OCD Medication: What the Research Shows

OCD medication mainly means SSRIs and clomipramine. What the main review found, whether higher doses help, how drugs compare with therapy, and the limits.

5 min read

Flat vector illustration of a woman with long brown hair in a blue plaid shirt, looking down at a sheet of paper she holds in a kitchen, with a mug and fruit on the table in front of her.

Key takeaways

  • A 2016 network meta-analysis of 54 trials and 6,652 adults found that SSRIs as a class (37 trials, 3,158 patients) and clomipramine (13 trials, 831 patients) reduced OCD symptoms more than drug placebo, by 3.49 and 4.72 points on the 40-point Yale-Brown scale.
  • Clomipramine was not shown to be better than SSRIs (a difference of 1.23 points, with a confidence interval running from 3.41 points better to 0.94 worse), so the two are not clearly ranked.
  • Psychological therapies had larger effects than medication in that analysis (behavioural therapy 14.48 points, cognitive therapy 13.36, cognitive behavioural therapy 5.37), but 80% of the therapy trials allowed people to keep taking stable doses of antidepressants.
  • A meta-analysis of 9 dose-comparison trials with 2,268 people found that higher SSRI doses were associated with better efficacy than low or medium doses in OCD, at the cost of more dropouts due to side-effects.
  • The main reviews left out people whose OCD had not responded to treatment, so they cannot say what works after the first drug fails, and none tells you which drug will suit you.

OCD medication works on average but modestly, and the main drugs are SSRIs and clomipramine. A 2016 network meta-analysis of 54 trials found that SSRIs as a class and clomipramine both reduced symptoms more than drug placebo, while behavioural and cognitive therapies had larger effects. [skapinakis-2016] This guide covers what that analysis and a dose-response review found, how medication compares with therapy, what the research could not show and what to ask a prescriber. Our overview of OCD covers the condition itself.

Which medications work for OCD?

SSRIs and clomipramine both do, and neither is clearly better. The 2016 analysis compared drugs and therapies with placebo using scores on the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), where a larger drop means fewer symptoms. It included 54 trials with 6,652 participants. Clomipramine (13 trials, 831 patients) reduced scores by 4.72 points versus drug placebo (95% credible interval 2.60 to 6.85), and SSRIs as a class (37 trials, 3,158 patients) by 3.49 points (1.81 to 5.12). [skapinakis-2016]

Clomipramine was not better than SSRIs: the difference was 1.23 points, with a credible interval from 3.41 points better to 0.94 points worse, which includes no difference at all. [skapinakis-2016] The Y-BOCS runs from 0 to 40, so a 3 to 5 point average drop is a real change but a limited one, which is worth knowing before starting a drug.

Does a higher dose help OCD?

Higher doses of SSRIs did better, though with more side-effects. A meta-analysis pooled 9 randomised, double-blind, placebo-controlled trials with 2,268 adults that compared several fixed doses of SSRIs with each other and with placebo. Compared with low or medium doses, higher doses were associated with improved efficacy, measured either by Y-BOCS score or by the proportion of responders. [bloch-2010]

Dose was not associated with the number of all-cause dropouts, but higher doses were associated with a significantly higher proportion of dropouts due to side-effects. The authors noted that this pattern stands in contrast to other conditions such as major depression, and that there are insufficient data to apply the findings to children or adolescents. [bloch-2010]

How does OCD medication compare with therapy?

In one analysis the therapies did better, with an important caveat. The 2016 network meta-analysis found behavioural therapy reduced Y-BOCS scores by 14.48 points (11 trials, 287 patients), cognitive therapy by 13.36 (6 trials, 172 patients) and cognitive behavioural therapy by 5.37 (9 trials, 231 patients), all compared with placebo. [skapinakis-2016]

Behavioural and cognitive therapy showed larger average effects than drugs, but the comparison has a catch Reported figures
0 4 8 12 16 Reduction in Y-BOCS score versus placebo (points) 3.49 SSRIs as a class 4.72 Clomipramine 5.37 Cognitive behavioural therapy 13.36 Cognitive therapy 14.48 Behavioural therapy

Mean reductions in Yale-Brown Obsessive Compulsive Scale scores compared with placebo, from the network meta-analysis by Skapinakis and colleagues (2016) of 54 trials and 6,652 adults. All values are mean differences compared with placebo as reported in the abstract, which does not describe what the therapy trials used as a control, and most therapy trials allowed stable antidepressant doses, so the bars are not a like-for-like contest.

The caveat is the one the authors state: a serious limitation was that most psychotherapy trials included patients who were taking stable doses of antidepressants (12 of the 15 explicitly allowed them). So the therapy results may partly reflect therapy added to medication. Their overall interpretation was that a range of interventions is effective, with considerable uncertainty about relative efficacy, and that combining therapy and medication is likely to be more effective than therapy alone, at least in severe OCD. [skapinakis-2016]

QuestionWhat the research foundCaveat
Do SSRIs work?3.49-point drop on the Y-BOCS versus drug placebo (37 trials)Modest on a 40-point scale
Is clomipramine better?Not shown (1.23-point difference, interval includes zero)Neither ranked above the other
Do higher doses help?Better efficacy than low or medium doses (9 trials)More dropouts due to side-effects
Therapy or drugs?Therapy effects larger, combination likely better in severe OCDMost therapy trials allowed stable antidepressants

What can this research not show?

It cannot show which drug suits you, what to do when the first drug fails or how quickly any of them work. Five limits matter most:

  • Treatment-resistant OCD is outside it. The network meta-analysis excluded studies that focused only on treatment-resistant populations, so it says little about what works after a first drug fails. [skapinakis-2016]
  • The therapy and drug comparison is not like for like. Therapy trials mostly allowed stable antidepressants, which the authors call a serious limitation. [skapinakis-2016]
  • Relative efficacy is uncertain. The authors describe considerable uncertainty and limitations in comparing treatments with each other. [skapinakis-2016]
  • The dose findings are for adults. The dose-response analysis says there are insufficient data to generalise to children or adolescents. [bloch-2010]
  • Speed, side-effects and stopping are not covered. We could not verify evidence on timelines, individual side-effect profiles or discontinuation, so those are questions for a prescriber.

What should you ask a prescriber?

Ask which drug is being proposed and why, what dose range is planned and what the plan is if it does not help. This section is our suggestion and is not something the reviews tested.

Useful questions are how long to give a drug before judging it, what side-effects to expect at higher doses given that dropouts for side-effects rise with dose, [bloch-2010] and whether therapy with exposure and response prevention should run alongside it. Our guide to exposure and response prevention covers that therapy, and CBT for intrusive thoughts covers the cognitive side. Do not stop a prescribed drug suddenly without speaking to the prescriber.

No screener on this site covers OCD. The self-assessment hub lists the seven we do have, and none is built for this question.

When to seek help

Speak to a doctor if obsessions or compulsions take up much of your day, cause distress or get in the way of work, relationships or sleep, or if you are already on medication that is not helping or is causing side-effects. If you feel unable to stay safe, contact your local emergency services or a crisis helpline.

How MyFreud can help

A record shows a prescriber what has changed. Daily mood tracking in MyFreud shows how your days run over weeks, and the notepad is somewhere to note how much time OCD took, side-effects and what you tried. It does not replace a doctor or a prescriber.

Download MyFreud and start today: App Store or Google Play.

Frequently asked questions

What is the best medication for OCD?

No single drug is shown to be best. A 2016 network meta-analysis of 54 trials found that SSRIs as a class and clomipramine both reduced OCD symptoms more than placebo, and clomipramine was not shown to be better than SSRIs. The choice usually depends on side-effects, other conditions and what you have tried before.

Do SSRIs work for OCD?

On average, yes, but modestly. In a 2016 network meta-analysis, SSRIs as a class reduced scores on the 40-point Yale-Brown Obsessive Compulsive Scale by 3.49 points more than drug placebo across 37 trials and 3,158 patients. That is a real effect, and it is smaller than the effect the same analysis found for behavioural therapy.

Do you need a higher dose of SSRI for OCD?

Possibly, and it comes with a cost. A meta-analysis of 9 fixed-dose trials with 2,268 adults found higher doses of SSRIs were associated with greater efficacy than low or medium doses, but also with a higher proportion of dropouts due to side-effects. The authors noted that this contrasts with depression, and that the data cannot be generalised to children or adolescents.

Is medication or therapy better for OCD?

In a 2016 analysis, psychological therapies had larger effects than medication, but a serious limitation was that most therapy trials included patients taking stable doses of antidepressants. The authors concluded that combining therapy and medication is likely to be more effective than therapy alone, at least in severe OCD.

Does OCD medication work straight away?

The reviews we could verify do not say how quickly the drugs work, so we cannot give a timeline from this evidence. A prescriber can tell you how long they would give a drug before judging it, which is worth asking at the start. Do not stop a prescribed medication suddenly without speaking to them.

References

  1. 1.Skapinakis P, et al. ( 2016). Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis. The Lancet Psychiatry. doi.org . doi:10.1016/S2215-0366(16)30069-4
  2. 2.Bloch MH, McGuire J, Landeros-Weisenberger A, Leckman JF, Pittenger C ( 2010). Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder. Molecular Psychiatry. doi.org . doi:10.1038/mp.2009.50